ENZO BIOCHEM INC - COM (ENZ)

Historical Portfolio Holders from Q1 2014 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
12.4M
Holdings value Q2 2024
$13.5M
Value change Q2 2024
-$1.82M
Grand Portfolio weight change Q2 2024
0%
Number of holders
38
Number of buys Q2 2024
12
Number of sells Q2 2024
-15
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 12.4M $13.5M -$1.82M $1.09 39
2024 Q1 13.8M $17.6M -$1.34M $1.27 39
2023 Q4 16.3M $22.7M -$253K $1.39 42
2023 Q3 16.5M $23.1M -$4.05M $1.40 37
2023 Q2 18.8M $34.7M -$1.84M $1.84 47
2023 Q1 19.8M $48.1M +$2.52M $2.43 52
2022 Q4 18.7M $26.8M -$533K $1.43 47
2022 Q3 20.5M $45.6M -$1.36M $2.23 41
2022 Q2 20.8M $43.1M -$1.09M $2.07 44
2022 Q1 21.4M $62M -$400K $2.90 42
2021 Q4 21.5M $68.9M -$9.56M $3.21 48
2021 Q3 23.4M $82.9M -$2.41M $3.54 57
2021 Q2 24.2M $76.6M -$9.64M $3.17 65
2021 Q1 25.1M $86.3M -$5.57M $3.44 75
2020 Q4 29.2M $73.6M +$1.18M $2.52 74
2020 Q3 25.3M $53.5M +$432K $2.11 75
2020 Q2 28.4M $63.5M -$455K $2.24 72
2020 Q1 28.6M $72.3M -$8.63M $2.53 64
2019 Q4 31.9M $84M -$1.54M $2.63 70
2019 Q3 32.6M $117M +$1.02M $3.60 80
2019 Q2 32.5M $109M +$3M $3.37 89
2019 Q1 32.2M $87.8M +$896K $2.73 74
2018 Q4 31.8M $88.3M -$4.74M $2.78 80
2018 Q3 31.3M $129M -$2.25M $4.12 91
2018 Q2 31.9M $166M +$2.32M $5.19 88
2018 Q1 30.6M $167M -$2.63M $5.48 98
2017 Q4 30.7M $251M +$6.17M $8.15 112
2017 Q3 29.8M $312M +$7.64M $10.47 111
2017 Q2 29.1M $321M +$11.5M $11.04 114
2017 Q1 28.3M $237M +$32.1M $8.37 108
2016 Q4 26.9M $187M +$1.91M $6.94 104
2016 Q3 23.7M $121M -$2.79M $5.09 108
2016 Q2 24.3M $145M +$14.3M $5.97 100
2016 Q1 22.1M $101M +$845K $4.55 91
2015 Q4 21.9M $98.6M +$6.35M $4.50 81
2015 Q3 21.1M $66.8M +$1.15M $3.17 76
2015 Q2 19.4M $58.8M -$3.87M $3.03 80
2015 Q1 21.9M $64.5M +$810K $2.95 80
2014 Q4 21.3M $94.7M +$5.86M $4.44 83
2014 Q3 19.6M $101M +$12.8M $5.15 90
2014 Q2 17.1M $89.9M +$21.2M $5.25 82
2014 Q1 13.3M $55.2M +$8.81M $4.16 59